Neutral impactIPO
Manipal Health IPO subscribed 15% on day 1; check GMP and other details | Will you bid?
News9live 1d ago·30 Jul 2026, 12:18 am
The initial public offering (IPO) for Manipal Health Enterprises has opened for subscription today, receiving a modest response of around 15% on the first day. The issue, which closes later this week, is being offered to raise capital for the company's expansion plans. The IPO consists of a fresh issue of shares and an offer for sale by existing promoters, aiming to tap into the growing healthcare sector in India.
This subscription level suggests a lukewarm start, indicating that the IPO may not have generated significant interest from retail investors at this early stage. The grey market premium (GMP), which reflects the unofficial trading price in the unlisted market, is currently at ₹1,050, implying a listing gain of approximately 37% over the issue price. This discrepancy between the subscription pace and the GMP is noteworthy and warrants close observation as the bidding period progresses.
Investors should keep a close watch on the subscription numbers over the next few days, particularly from the Qualified Institutional Buyers (QIB) and Non-Institutional Investors (NII) categories. A surge in demand from these larger investors could boost the issue's response. Furthermore, monitoring the company's financial performance and the overall sentiment in the healthcare sector will be crucial for making an informed decision on whether to apply for the IPO.
Excerpt from News9live
Kolkata: On July 29, the first day of the bidding window, Manipal Health Enterprises IPO was subscribed overall 0.15 times — 0.27 times in the retail category, 0.15 times in QIB category and 0.08 times in the NII category. Manipal Health Enterprises IPO is book built issue designed to raise Rs 9,275.22 crores through…Read the original at News9live
Key takeaways
- Category: IPO.
- Assessed as a significant, market-relevant update.
Why it matters
A meaningful update worth tracking. Use the price and stock snapshot to gauge how the market is responding.
